The Impact of the Women's Health Initiative on Clinical Practice

Abstract

Get full access to this article

View all access options for this article.

References

1. Writing Group for the Women's Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.

2. Enserink M . Despite safety concerns, U.K. hormone study to proceed. Science 2002;297:492-492.

3. Bush TL . The not so randomized clinical trial. Int J Fertil 2001;46:56-59.

4. Mikkola TS , Clarkson TB . Estrogen replacement therapy: Atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619.

5. Herrington DM , Espeland MA , Crouse JR 3rd , et al. Estrogen replacement and brachial artery flow-mediated vasodilatation in older women. Arterioscl Thromb Vasc Biol 2001;21:1955-1961.

6. Hodis HN , Mack WJ , Lobo RA , et al. Estrogen in the prevention of atherosclerosis: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939-953.

7. Grady D , Wenger NK , Herrington D , et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-696.